Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
AIDS and Behavior
Published in: AIDS and Behavior 9/2013

01-11-2013 | Original Paper

A Randomized Trial of a Behavioral Intervention for High Risk Substance-Using MSM

Authors: Steven P. Kurtz, Ronald D. Stall, Mance E. Buttram, Hilary L. Surratt, Minxing Chen

Published in: AIDS and Behavior | Issue 9/2013

Login to get access

Abstract

Substance-using men who have sex with men (MSM) are among the groups at highest risk for HIV infection in the United States. We report the results of a randomized trial testing the efficacy of a small group sexual and substance use risk reduction intervention based on empowerment theory compared to an enhanced efficacious control condition among 515 high risk not-in-treatment MSM substance users. Effect sizes for sexual risk and substance use outcomes were moderate to large: HIV transmission risk frequency, d = 0.71 in the control versus 0.66 in the experimental group; number of anal sex partners, d = 1.04 versus 0.98; substance dependence symptoms, d = 0.49 versus 0.53; significant differences were not observed between conditions. Black MSM reduced their risks at a greater rate than White or Latino men. The findings point to a critically important research agenda to reduce HIV transmission among MSM substance users.
Literature
1.
2.
Carey JW, Mejia R, Bingham T, Ciesielski C, Gelaude D, Herbst JH, et al. Drug use, high-risk sex behaviors, and increased risk for recent hiv infection among men who have sex with men in chicago and los angeles. AIDS Behav. 2009;13(6):1084–96.PubMedCrossRef
3.
Plankey MW, Ostrow DG, Stall R, Cox C, Li X, Peck JA, et al. The relationship between methamphetamine and popper use and risk of HIV user in the Multicenter AIDS Cohort Study. J Acquir Immune Defic Syndr. 2007;1(45):85–92.CrossRef
4.
Chesney MA, Barrett DC, Stall R. Histories of substance use and risk behavior: precursors to HIV seroconversion in homosexual men. Am J Public Health. 1998;88(1):113–6.PubMedCrossRef
5.
Stall RD, Purcell DW. Intertwining epidemics: a review of research on substance use among men who have sex with men and its connection to the AIDS epidemic. AIDS Behav. 2000;4(2):181–92.CrossRef
6.
Koblin BA, Husnik MJ, Colfax G, Huang Y, Madison M, Mayer K, et al. Risk factors for HIV infection among men who have sex with men. AIDS. 2006;20(5):731–9.PubMedCrossRef
7.
Ostrow DG, Plankey MW, Cox C, Li X, Shoptaw S, Jacobson LP, et al. Specific sex drug combinations contribute to the majority of recent HIV seroconversions among MSM in the MACS. J Acquir Immune Defic Syndr. 2009;51(3):349–55.PubMedCrossRef
8.
Lyles CM, Kay LS, Crepaz N, Herbst JH, Passin WF, Kim AS, et al. Best-evidence interventions: findings from a systematic review of HIV behavioral interventions for US populations at high risk 2000–2004. Am J Public Health. 2007;97(1):133–43.PubMedCrossRef
9.
Herbst JH, Sherba RT, Crepaz N, De Luca JB, Zohrabyan L, Stall RD, et al. A meta-analytic review of hiv behavioral interventions for reducing sexual risk behavior of men who have sex with men. J Acquir Immune Defic Syndr. 2005;39(2):228–41.PubMed
10.
Johnson WD, Holtgrave DR, McClellan WM, Flanders WD, Hill AN, Goodman M. HIV intervention research for men who have sex with men: a 7-year update. AIDS Educ Prev. 2005;17(6):568–89.PubMedCrossRef
11.
12.
Stall RD, Paul JP, Barrett DC, Crosby GM, Bein E. An outcome evaluation to measure changes in sexual risk-taking among gay men undergoing substance use disorder treatment. J Stud Alcohol. 1999;60(6):837–45.PubMed
13.
Shoptaw S, Reback CJ, Peck JA, Yang X, Rotheram-Fuller E, Larkins S, et al. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men. Drug Alcohol Dep. 2005;78(2):125–34.CrossRef
14.
Mansergh G, Koblin BA, McKirnan DJ, Hudson SM, Flores SA, Wiegand RE, et al. An intervention to reduce HIV risk behavior of substance-using men who have sex with men: a two-group randomized trial with a nonrandomized third group. PLoS ONE. 2010;7(8):1–9.
15.
Zimmerman MA. Empowerment theory: psychological, organizational and community levels of analysis. In: Rappaport J, Seidman E, editors. Handbook of community psychology. New York: Plenum Press; 2000. p. 43–63.CrossRef
16.
Kamb ML, Fishbein M, Douglas JM, Rhodes F, Rogers J, Bolan G, et al. Efficacy of risk-reduction counseling to prevent Human Immunodeficiency Virus and sexually transmitted diseases. JAMA. 1998;280(13):1161–7.PubMedCrossRef
17.
Singer M. A dose of drugs, a touch of violence, a case of AIDS: conceptualizing the SAVA syndemic. Free Inq Creat Soc. 1996;24(2):99–110.
18.
Smith DM, Lavery GG. Gay and lesbian families in the united states: same-sex unmarried partner households: a preliminary analysis of 2000 United States census data, a Human Rights Campaign report. Washington, D.C.: Human Rights Campaign; 2001.
19.
20.
Centers for Disease Control and Prevention. 2005. HIV prevalence, unrecognized infection, and HIV testing among men who have sex with men—five U.S. cities, June 2004–April 2005. MMWR Morbidity and Mortality Weekly Report, June 24;54(24):597-601.
21.
Egan J, Frye V, Kurtz SP, Latkin C, Chen M, Tobin K, et al. Migration, neighborhoods, and networks: approaches to understanding how urban environmental conditions affect syndemic adverse health outcomes among gay, bisexual and other men who have sex with men. AIDS Behav. 2011;15:S35–50.PubMedCrossRef
22.
Dennis ML, Titus JC, White MK, Unsicker JI, Hodgkins D. Global appraisal of individual needs-initial (GAIN-I). Bloomington: Chestnut Health Systems; 2002.
23.
Zimmerman MA. Psychological empowerment: issues and illustrations. Am J Community Psychol. 1995;23(5):581–99.PubMedCrossRef
24.
25.
Kurtz SP. Between Kansas and Oz: drugs, sex, and the search for gay identity in the fast lane. In: Hammack PL, Cohler BJ, editors. The story of sexual identity: narrative perspectives on the gay and lesbian life course. New York: Oxford University Press; 2009.
26.
Kurtz SP. Post-circuit blues: motivations and consequences of crystal meth use among gay men in Miami. AIDS Behav. 2005;9(1):63–72.PubMedCrossRef
27.
Fergus S, Zimmerman MA. Adolescent resilience: a framework for understanding health development in the face of risk. Annu Rev Public Health. 2005;26:399–419.PubMedCrossRef
28.
Wolin Sybil WS. Resilience among youth growing up in substance-abusing families. Pediatr Clin North Am. 1995;42(2):415–29.
29.
Kurtz SP, Buttram ME, Surratt HL, Ron S. Resilience, syndemic factors, and serosorting behaviors among HIV-positive and HIV-negative substance-using MSM. AIDS Educ Prev. 2012;24(3):193–205.PubMedCrossRef
30.
Noar SM, Black HG, Pierce LB. Efficacy of computer technology-based HIV prevention interventions: a meta-analysis. AIDS. 2009;23:107–15.PubMedCrossRef
31.
Hodder RK, Daly J, Freund M, Bowman J, Hazell T, Wiggers J. A school-based resilience intervention to decrease tobacco, alcohol and marijuana use in high school students. BMC Public Health. 2011;11:722.PubMedCrossRef
32.
Burton Nicola PKI, Brown Wendy J. Feasibility and effectiveness of psychosocial resilience training: a pilot study of the ready program. Psychol Health Med. 2010;15(3):266–77.PubMedCrossRef
33.
Griffin JP, Holiday RC, Frazier E, Braithwaite RL. The BRAVE (building resiliency and vocational excellence) program: Evaluation findings for a career-oriented substance abuse and violence preventive intervention. J Healthc Poor Underserved. 2009;20(3):798–816.CrossRef
34.
Steinhardt Mary DC. Evaluation of a resilience intervention to enhance coping strategies and protective factors and decrease symptomatology. J Am Coll Health. 2008;56((4):445–53.PubMedCrossRef
35.
Buttram ME, Kurtz SP, Surratt HL. Substance use and sexual risk mediated by social support among black men. J Community Health. 2013;38(1):62–9.PubMedCrossRef
36.
Epstein EE, Drapkin ML, Yusko DA, Cook SM, McCrady BS, Jensen NK. Is alcohol assessment therapeutic? Pretreatment change in drinking among alcohol-dependent women. J Stud Alcohol. 2005;66(3):369–78.PubMed
37.
Clifford PR, Maisto SA. Subject reactivity effects and alcohol treatment outcome research. J Stud Alcohol. 2000;61(6):787–93.PubMed
38.
Kypri K, Langley JD, Saunders JB, Cashell-Smith ML. Assessment may conceal therapeutic benefit: findings from a randomized controlled trial for hazardous drinking. Addiction. 2007;102(1):62–70.PubMedCrossRef
39.
Weinhardt LS, Carey KB, Carey MP. HIV risk sensitization following a detailed sexual behavior interview: a preliminary investigation. J Behav Med. 2000;23(4):393–8.PubMedCrossRef
40.
Halkitis PN, Mukherjee PP, Palamar JJ. Multi-level modeling to explain methamphetamine use among gay and bisexual men. Addiction. 2007;102(Supplement 1):76–83.PubMedCrossRef
41.
National Institute of Mental Health (NIMH) Multisite HIV Prevention Trial Group. The NIMH Multisite HIV Prevention Trial: reducing HIV sexual risk behavior. Science. 1998;280(5371):1189–894.
42.
Lightfoot M, Rotheram-Borus MJ, Comulada S, Gundersen G, Reddy V. Self-monitoring of behaviour as a risk reduction strategy for persons living with HIV. AIDS Care. 2007;19(6):757–63.PubMedCrossRef
43.
Carpenter KM, Stoner SA, Mikko AN, Dhanak LP, Parsons JT. Efficacy of a web-based intervention to reduce sexual risk in men who have sex with men. AIDS Behav. 2010;14(3):549–57.PubMedCrossRef
44.
Kvalem IL, Sundet JM, Rivo KL, Eilersten DA, Bakketeig LS. The effect of sex education on adolescents’ use of condoms: applying the solomon four-group design. Health Educ Q. 1996;23(1):34–47.PubMedCrossRef
45.
Marsden J, Stillwell G, Barlow H, Boys A, Taylor C, Hunt N, et al. An evaluation of a brief motivational intervention among young ecstasy and cocaine users: no effect on substance and alcohol use outcomes. Addiction. 2006;101:1014–26.PubMedCrossRef
46.
Kurtz SP, Surratt HL, Buttram ME, Levi-Minzi MA, Chen M. Interview as intervention: the case of young adult multidrug users in the club scene. J Subst Abuse Treat. 2012;44(3):301–8.PubMedCrossRef
47.
Cohen M, Chen Y, McCauley M, Gamble T, Hosseinipour M, Kumarasamy N, et al. Prevention of HIV-1 infection with early antiretroviral therapy. N Engl J Med. 2011;11(365):469–505.
48.
Smith D, Grant R, Weidle P, Lansky A, Mermin J, Fenton K, et al. Interim guidance: preexposure prophylaxis for the prevention of HIV infection in men who have sex with men. MMWR Morb Mortal Wkly Rep. 2011;60(3):65–8.
49.
Cohen MS, Muessing KE, Smith MK, Powers KA, Kashuba ADM. Antiretroviral agents and hiv prevention: controversies, conflicts, and consenus. AIDS. 2012;26:1585–98.PubMedCrossRef
Metadata
Title
A Randomized Trial of a Behavioral Intervention for High Risk Substance-Using MSM
Authors
Steven P. Kurtz
Ronald D. Stall
Mance E. Buttram
Hilary L. Surratt
Minxing Chen
Publication date
01-11-2013
Publisher
Springer US
Published in
AIDS and Behavior / Issue 9/2013
Print ISSN: 1090-7165
Electronic ISSN: 1573-3254
DOI
https://doi.org/10.1007/s10461-013-0531-z

Other articles of this Issue 9/2013

AIDS and Behavior 9/2013 Go to the issue

Original Paper

WiLLOW: Reaching HIV-Positive African-American Women Through a Computer-Delivered Intervention

Original Paper

A Comparison Study of Methods for Measuring Retention in HIV Medical Care

Original Paper

Personal Health Record Use and Its Association with Antiretroviral Adherence: Survey and Medical Record Data from 1871 US Veterans Infected with HIV

Original Paper

From Research to Practice: Lay Adherence Counsellors’ Fidelity to an Evidence-Based Intervention for Promoting Adherence to Antiretroviral Treatment in the Western Cape, South Africa

Original Paper

Supportive-Expressive and Coping Group Teletherapies for HIV-Infected Older Adults: A Randomized Clinical Trial

Original Paper

Summary Measures of Adherence Using Pill Counts in Two HIV Prevention Trials: The Need for Standardisation in Reporting
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits